About 1 result found for searched term "DCC-2036" (0.139 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1702 | DCC-2036 | Src-bcr-Abl |
| Rebastinib | ||
| DCC-2036 is an ABL inhibitor with IC50 of 0.8 and 2 nM for u-ABL1native and p-ABL1native, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
